JOLIMARK (02028) has released its interim results for the six months ended June 30, 2026, showing a reduction in its attributable loss.
The company recorded revenue of RMB 62.007 million, marking a year-on-year decline of 11.66%. Meanwhile, the loss attributable to shareholders narrowed to RMB 24.359 million, representing a decrease of 21.26% compared to the prior corresponding period. Basic loss per share stood at RMB 0.039.
According to the company's announcement, the primary factors driving the attributable loss in the first half of 2026 include weak demand for printers stemming from the comprehensive rollout of digital electronic invoicing across mainland China. Additionally, the medical products segment has yet to achieve meaningful scale, and the company recognized asset impairments during the period.